|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
1 From the Pulmonary Diseases, Critical Care, and Occupational Medicine Division, Department of Internal Medicine, The University of Iowa College of Medicine, Iowa City
Study objectives: To determine the effect of glucocorticoids on grain dust-induced airflow obstruction and airway inflammation.
Design: Randomized controlled trial.
Setting: University hospital.
Participants: Health volunteers.
Interventions: Two randomized, placebo-controlled trials, each studying 10 healthy volunteers who were pretreated with either triamcinolone acetonide (Azmacort) oral inhaler 4 puffs twice daily (800 µg daily) for 7 consecutive days or IV hydrocortisone (3 µg/kg/min) as a 14-h continuous infusion, then subjected to a controlled inhalation exposure to corn dust extract (CDE) (endotoxin exposure dose of 3 µg/kg). A single-blind, crossover study design was performed for each trial enrolling 10 healthy, lifetime nonsmokers, with no history of lung disease or environmental exposure to grain dust.
Measurements and results: Following each inhalation exposure to CDE, spirometry was performed at regular intervals and BAL was performed at 4 h. Both treatment and placebo groups demonstrated significant decrements in spirometry and increments in BAL cellularity following CDE inhalation compared with placebo. Inhaled steroid treatment resulted in a significantly higher FEV1 only at the 2-h time point following CDE inhalation with no significant differences observed in the BAL total cell concentration or cellular differential compared with placebo. IV hydrocortisone treatment resulted in a significantly higher FEV1 and FVC between 2 and 4 h after CDE inhalation, as well as significant reductions in the BAL total cell, macrophage, and eosinophil concentrations. Interestingly, the concentration of tumor necrosis factor-
and interleukin-8 in the BAL fluid was also decreased following treatment with IV glucocorticoids.
Conclusions: These results demonstrate that glucocorticoids, administered IV and perhaps by inhalation, have a mildly protective effect on airflow obstruction and airway inflammation induced by inhalation of grain dust.
Key Words: airway injury asthma glucocorticoids grain dust
Submitted on June 25, 1997
Accepted on August 25, 1000
This article has been cited by other articles:
![]() |
I. Rubinstein and S. G. Von Essen Hog barn dust extract increases macromolecular efflux from the hamster cheek pouch J Appl Physiol, July 1, 2006; 101(1): 128 - 134. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. KLINE, J. D. COWDEN, G. W. HUNNINGHAKE, B. C. SCHUTTE, J. L. WATT, C. L. WOHLFORD-LENANE, L. S. POWERS, M. P. JONES, and D. A. SCHWARTZ Variable Airway Responsiveness to Inhaled Lipopolysaccharide Am. J. Respir. Crit. Care Med., July 1, 1999; 160(1): 297 - 303. [Abstract] [Full Text] |
||||
![]() |
D. A. Schwartz, C. L. Wohlford-Lenane, T. J. Quinn, and A. M. Krieg Bacterial DNA or Oligonucleotides Containing Unmethylated CpG Motifs Can Minimize Lipopolysaccharide-Induced Inflammation in the Lower Respiratory Tract Through an IL-12-Dependent Pathway J. Immunol., July 1, 1999; 163(1): 224 - 231. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Akhter, H. Ikezaki, X.-P. Gao, and I. Rubinstein Dexamethasone attenuates grain sorghum dust extract-induced increase in macromolecular efflux in vivo J Appl Physiol, May 1, 1999; 86(5): 1603 - 1609. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |